JNJ Research
Johnson & Johnson
2.40%
Forward yield
$5.360 / yr per share
Yield percentile (5y)
P 21
2.3% (P10)2.7% (med)3.0% (P90)
Quality score
91/100
Strong · Moderate payout risk
Annual / share
$5.360
Quarterly · next ex-date 08-25 (80d)
vs 5y P90 reference
+23%
$223.57 vs $172.38 (5y P90 price)
Refreshed 2026-06-06Data coverage High — 65y history
01Fundamentals
Johnson & Johnson is a top-tier dividend stock for income investors, boasting 65 consecutive years of dividend growth with a robust 13.01% 5Y dividend growth rate. Its 60.25% payout ratio is very safe, backed by $19.31B in Free Cash Flow.
Bull caseJNJ's dividend safety is exceptional, marked by a 20.0 payout_safety score and a strong 26.416% ROE, while its 65 consecutive years of increases reflect a best-in-class 20.0 continuity score and 13.01% 5Y dividend growth.
Bear caseFor investors solely focused on current income, the 2.279% dividend yield is lower than risk-free alternatives, despite robust 13.01% 5Y dividend growth and a 27.00 trailing P/E.
02Risk & quality
| GAAP payout ratio | Moderate · 60.3% |
| Overall quality score | 91 / 100 · Strong |
Score breakdown — five dimensions, each /2020 + 20 + 18 + 9 + 14 = 91
20.0/20
Consistency
20.0/20
Payout safety
17.6/20
Moat
↓
8.7/20
Growth rate
14.3/20
Balance sheet
- Consistency 20.0/20 — JNJ has paid an uninterrupted dividend for 65 straight years, putting it in the Dividend King tier — the small US-listed club of 50+ year streaks. This dimension caps at 10 years, so anything past that sits well above the ceiling.
- Payout safety 20.0/20 — JNJ pays out 60.3% of GAAP earnings as dividends — still inside the safe band, with some headroom before reaching 80%, the level commonly flagged as strained. Manageable as long as earnings hold up.
- Moat 17.6/20 — Scores how protected JNJ's earnings stream is from competition. Operating in Healthcare, JNJ benefits from the kind of brand pricing power, regulatory position, or scale that lets margins hold up through economic cycles. Cyclical or commodity-driven sectors typically score in the single digits here.
- Growth rate 8.7/20 — JNJ's dividend grew about 13.0% per year over 5 years — solid by absolute standards, but a notch below the 15-20% pace seen at growth-oriented dividend payers (think SCHD constituents). Familiar pattern for established staples already paying out most of what they earn — the runway for further hikes naturally narrows once payout ratios climb.
- Balance sheet 14.3/20 — A composite of return-on-equity and inverse leverage. JNJ's 26.4% ROE and 68% debt-to-equity leaves this dimension in the middle of the pack — neither flagged for weakness nor in the financial-flexibility tier of top-scoring names.
03Price reference
$10,000at current price →$240/ yr in dividends
Math: 2.40% forward yield. Historical 5y DGR is 13.0%/yr — past growth does not guarantee future results.
Below are statistical price references from the last 5 years of trading, anchored to historical drawdown events. They describe where the price has been — not where it should be.
$142.01
$172.38
$223.57
5y P10
5y P90
Now
| Current price | $223.57 |
| 5y P90 reference (high-yield 10% tail) | $172.38 — 22.9% lower |
| 5y P10 reference (low-yield 10% tail) | $142.01 — 36.5% lower |
| 5y max observed yield (at P10 price) | 3.4% |
| Annual dividend (frozen forward) | $5.360 / share · 2.40% yield |
Historical anchor · 2008-10 Global Financial Crisis
Low $28.10 · drawdown 21 days · yield reached 6.1%
Lehman collapse triggered global credit freeze; S&P fell ~50% peak-to-trough.
Important — this is reference data, not investment advice.
Quality scores, percentiles, and price references are statistical summaries of historical data computed by our research methodology from public market data, refreshed daily. They do not constitute a buy / sell / hold recommendation, do not account for your personal financial situation, tax bracket, or goals, and past performance does not predict future results. Consult a registered investment advisor before making investment decisions. divcalc.io is not a registered investment advisor.
Quality scores, percentiles, and price references are statistical summaries of historical data computed by our research methodology from public market data, refreshed daily. They do not constitute a buy / sell / hold recommendation, do not account for your personal financial situation, tax bracket, or goals, and past performance does not predict future results. Consult a registered investment advisor before making investment decisions. divcalc.io is not a registered investment advisor.